TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
15 hedge funds and large institutions have $1.24M invested in Titan Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-11
Holders Change %
-42.31%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
2
Closed
11
Calls
$624K
Puts
$184K
Net Calls
+$440K
Net Calls Change
+$436K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$195K |
2 |
ARTA
A.R.T. Advisors
New York
|
+$47K |
3 |
Northern Trust
Chicago,
Illinois
|
+$11.9K |
4 |
UBS Group
Zurich,
Switzerland
|
+$8.62K |
5 |
Morgan Stanley
New York
|
+$5K |